Literature DB >> 23458546

Bio-inspired liposomal thrombomodulin conjugate through bio-orthogonal chemistry.

Hailong Zhang1, Jacob Weingart, Rui Jiang, Jianhao Peng, Qingyu Wu, Xue-Long Sun.   

Abstract

We report the synthesis of bioinspired liposomal thrombomodulin (TM) conjugates by chemoselective and site-specific liposomal conjugation of recombinant TM at C-terminus. TM is an endothelial cell membrane protein that acts as a major cofactor in the protein C anticoagulant pathway. To closely mimic membrane protein structural features of TM, we proposed membrane-mimetic re-expression of recombinant TM onto liposome. A recombinant TM containing the EGF-like 456 domains and an azidohomoalanine at C-terminus was expressed in E. coli. Conjugation of the recombinant TM onto liposome via Staudinger ligation and copper-free click chemistry were investigated as an optimal platform for exploring membrane protein TM's activity, respectively. The bioinspired liposomal TM conjugates were confirmed with Western blotting and protein C activation activity. The recombinant TM-liposome conjugates showed a 2-fold higher k(cat)/K(m) value for protein C activation than that of the recombinant TM alone, which indicated that the lipid membrane has a beneficiary effect on the recombinant TM's activity. The reported liposomal protein conjugate approach provides a rational design strategy for both studying membrane protein TM's functions and generating a membrane protein TM-based anticoagulant agent.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23458546      PMCID: PMC3630279          DOI: 10.1021/bc300399f

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  41 in total

Review 1.  Vascular-bed--specific hemostasis and hypercoagulable states.

Authors:  R D Rosenberg; W C Aird
Journal:  N Engl J Med       Date:  1999-05-20       Impact factor: 91.245

2.  Structure-function studies of the epidermal growth factor domains of human thrombomodulin.

Authors:  J F Parkinson; M Nagashima; I Kuhn; J Leonard; J Morser
Journal:  Biochem Biophys Res Commun       Date:  1992-06-15       Impact factor: 3.575

3.  In vitro anticoagulant properties of a minimum functional fragment of human thrombomodulin and in vivo demonstration of its benefit as an anticoagulant in extracorporeal circulation using a monkey model.

Authors:  M Suzuki; M Mohri; S Yamamoto
Journal:  Thromb Haemost       Date:  1998-02       Impact factor: 5.249

4.  Positional isomers of monopegylated interferon alpha-2a: isolation, characterization, and biological activity.

Authors:  S P Monkarsh; Y Ma; A Aglione; P Bailon; D Ciolek; B DeBarbieri; M C Graves; K Hollfelder; H Michel; A Palleroni; J E Porter; E Russoman; S Roy; Y C Pan
Journal:  Anal Biochem       Date:  1997-05-01       Impact factor: 3.365

5.  The first mutation identified in the thrombomodulin gene in a 45-year-old man presenting with thromboembolic disease.

Authors:  A K Ohlin; R A Marlar
Journal:  Blood       Date:  1995-01-15       Impact factor: 22.113

6.  Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells.

Authors:  J F Parkinson; B W Grinnell; R E Moore; J Hoskins; C J Vlahos; N U Bang
Journal:  J Biol Chem       Date:  1990-07-25       Impact factor: 5.157

7.  TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex.

Authors:  L Bajzar; J Morser; M Nesheim
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

8.  Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin.

Authors:  Q Y Wu; J P Sheehan; M Tsiang; S R Lentz; J J Birktoft; J E Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

9.  Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor.

Authors:  L Bajzar; R Manuel; M E Nesheim
Journal:  J Biol Chem       Date:  1995-06-16       Impact factor: 5.157

10.  A strain-promoted [3 + 2] azide-alkyne cycloaddition for covalent modification of biomolecules in living systems.

Authors:  Nicholas J Agard; Jennifer A Prescher; Carolyn R Bertozzi
Journal:  J Am Chem Soc       Date:  2004-11-24       Impact factor: 15.419

View more
  10 in total

1.  Glyco-modification of protein with O-cyanate chain-end functionalized glycopolymer via isourea bond formation.

Authors:  Valentinas Gruzdys; Hailong Zhang; Xue-Long Sun
Journal:  J Carbohydr Chem       Date:  2014       Impact factor: 1.667

2.  Recombinant and chemo-/bio-orthogonal synthesis of liposomal thrombomodulin and its antithrombotic activity.

Authors:  Lin Wang; Rui Jiang; Yang Liu; Maosheng Cheng; Qingyu Wu; Xue-Long Sun
Journal:  J Biosci Bioeng       Date:  2017-07-08       Impact factor: 2.894

3.  A clickable and photocleavable lipid analogue for cell membrane delivery and release.

Authors:  Shahrina Alam; Daiane S Alves; Stuart A Whitehead; Andrew M Bayer; Christopher D McNitt; Vladimir V Popik; Francisco N Barrera; Michael D Best
Journal:  Bioconjug Chem       Date:  2015-05-15       Impact factor: 4.774

4.  Artificial Membrane Fusion Triggered by Strain-Promoted Alkyne-Azide Cycloaddition.

Authors:  Stuart A Whitehead; Christopher D McNitt; Samuel I Mattern-Schain; Adam J Carr; Shahrina Alam; Vladimir V Popik; Michael D Best
Journal:  Bioconjug Chem       Date:  2017-03-14       Impact factor: 4.774

5.  End-point modification of recombinant thrombomodulin with enhanced stability and anticoagulant activity.

Authors:  Xia Liu; Mallorie Boron; Yu Zhao; Xue-Long Sun
Journal:  Eur J Pharm Sci       Date:  2019-09-09       Impact factor: 4.384

6.  Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towards Conquering Desmoplasia?

Authors:  Girgis Obaid; Shazia Bano; Srivalleesha Mallidi; Mans Broekgaarden; Jerrin Kuriakose; Zachary Silber; Anne-Laure Bulin; Yucheng Wang; Zhiming Mai; Wendong Jin; Diane Simeone; Tayyaba Hasan
Journal:  Nano Lett       Date:  2019-10-04       Impact factor: 11.189

7.  Targeted antithrombotic protein micelles.

Authors:  Wookhyun Kim; Carolyn Haller; Erbin Dai; Xiowei Wang; Christoph E Hagemeyer; David R Liu; Karlheinz Peter; Elliot L Chaikof
Journal:  Angew Chem Int Ed Engl       Date:  2014-12-10       Impact factor: 15.336

8.  Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect.

Authors:  Colin F Greineder; Jacob B Brenza; Ronald Carnemolla; Sergei Zaitsev; Elizabeth D Hood; Daniel C Pan; Bi-Sen Ding; Charles T Esmon; Ann Marie Chacko; Vladimir R Muzykantov
Journal:  FASEB J       Date:  2015-05-07       Impact factor: 5.191

9.  Chemical Reactive Anchoring Lipids with Different Performance for Cell Surface Re-engineering Application.

Authors:  Pratima Vabbilisetty; Mallorie Boron; Huan Nie; Evgeny Ozhegov; Xue-Long Sun
Journal:  ACS Omega       Date:  2018-02-07

10.  Peptide density targets and impedes triple negative breast cancer metastasis.

Authors:  Daxing Liu; Peng Guo; Craig McCarthy; Biran Wang; Yu Tao; Debra Auguste
Journal:  Nat Commun       Date:  2018-07-04       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.